VERTEX PHARMACEUTICALS INCORPORATED
Proposal 1.
Election of JEFFREY M. LEIDEN as director
Caisse vote:
For
Applicable policy or principle:
PR_05_01
Proposal 1.
Election of BRUCE I. SACHS as director
Caisse vote:
For
Applicable policy or principle:
PR_05_01
Proposal 1.
Election of SANGEETA N. BHATIA as director
Caisse vote:
For
Applicable policy or principle:
PR_05_01
Proposal 2.
AMENDMENT TO OUR ARTICLES OF ORGANIZATION THAT INCREASES THE NUMBER OF SHARES AUTHORIZED FOR ISSUANCE FROM 300 MILLION TO 500 MILLION.
Caisse vote:
For
Applicable policy or principle:
PR_03
Proposal 3.
AMENDMENT AND RESTATEMENT OF OUR 2013 STOCK AND OPTION PLAN THAT, AMONG OTHER THINGS, INCREASES THE NUMBER OF SHARES AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 7.8 MILLION SHARES.
Caisse vote:
Against
Applicable policy or principle:
PR_07_02
Proposal 4.
RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2015.
Caisse vote:
For
Applicable policy or principle:
PR_06
Proposal 5.
ADVISORY VOTE ON OUR NAMED EXECUTIVE OFFICER COMPENSATION.
Caisse vote:
Against
Applicable policy or principle:
PR_07_06
Proposal 6.
SHAREHOLDER PROPOSAL REGARDING A PROXY ACCESS BY-LAW.
Caisse vote:
For
Applicable policy or principle:
PR_05_04
Proposal 7.
SHAREHOLDER PROPOSAL REQUESTING A REPORT ON SPECIALTY DRUG PRICES.
Caisse vote:
Against
Applicable policy or principle:
PR_12